We are following 60 patients with morphea and/or linear scleroderma at the Hospital for Sick Children, Toronto. Lesions may vary in depth from epidermal changes resembling lichen sclerosis, to superficial and deep dermal changes. The subcutaneous tissue, bone and muscle may be involved. There is no good clinical marker of the disease. Because of the variation in the time to cure, it is difficult to evaluate treatment regimens. We are currently using methotrexate weekly either orally or subcutaneously and monthly pulsed steroids for three months.
CITATION STYLE
Krafchik, B. R. (1999). Localized morphea in children. In Advances in Experimental Medicine and Biology (Vol. 455, pp. 49–54). Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-4857-7_7
Mendeley helps you to discover research relevant for your work.